Digital Therapeutics and the Future of Health

Virtual Panel Discussion

October 8, 2020
9:00am PT | 12:00pm ET

Digital therapeutics (DTx) is reshaping the landscape of chronic disease management and care, enabling patients to leverage technology to take control of their own health. DTx is the convergence of healthcare and software. These technological advancements allow providers and customers to engage in new, innovative ways.

The global digital therapeutics market is expected to grow to $6.9 billion by 2025. This exponential growth gives life science companies the opportunity to lead the next generation of care management and shape the future of healthcare. Now that the benefits of DTx are becoming clearer the industry is rapidly moving towards the commercialization of these solutions.

Join us for a virtual panel discussion where we will assess the growth of the industry so far, share best practices for DTx commercialization and look towards the next phases of industry growth.


Laura Furmanski
Managing Partner & Director
Adam Kaufman
Head of DTxL
Gunnar Trommer
Managing Partner & Director
BCG Digital Ventures
Ami Karnik
Peggy Baxter
Chief of Staff
Dharmesh Syal
Ed Cox
Executive Vice President, Strategic Aliances & Global Head of Digital Medicine
Vicky Zhou
Melinda Decker
Chief Commercial Officer
Register Now

Presented by